HSP90i
HSP90i is a HSP90 inhibitor. HSP90i can be used as a drug intermediate to synthesize LYTACs, such as dPDL1-4[2].
Product Specifications
CAS Number
1472616-48-0
UNSPSC
12352208
Target
Drug Intermediate; HSP
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
CC(C1=C(C=C(C(C2=NN=C(N2C3=CC=C(C=C3)CN4CCNCC4)O)=C1)O)O)C
Molecular Formula
C22H27N5O3
Molecular Weight
409.48
References & Citations
[1]Zhang D, et al. Extracellular HSP90-Facilitated Degradation of Extracellular and Membrane Proteins by Bifunctional Small Molecules. J Med Chem. 2025 Jun 26;68 (12) :12641-12657.|[2]Rastogi S, et al. An update on the status of HSP90 inhibitors in cancer clinical trials. Cell Stress Chaperones. 2024 Aug;29 (4) :519-539.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
131989-APC 100 µL
PSMD9 (26S Proteasome non-ATPase Regulatory Subunit 9, 26S Proteasome Regulatory Subunit p27) (APC)
Sign In for Pricing
View Details PROTQ15782-1 10 µg
CHI3L2 Human, Chitinase 3-Like 2 Human Recombinant Protein, Sf9
Sign In for Pricing
View Details